A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial☆
| Autor: | Park, S.H., Lim, D.H., Sohn, T.S., Lee, J., Zang, D.Y., Kim, S.T., Kang, J.H., Oh, S.Y., Hwang, I.G., Ji, J.H., Shin, D.B., Yu, J.I., Kim, K.-M., An, J.Y., Choi, M.G., Lee, J.H., Kim, S., Hong, J.Y., Park, J.O., Park, Y.S., Lim, H.Y., Bae, J.M., Kang, W.K. |
|---|---|
| Zdroj: | In Annals of Oncology March 2021 32(3):368-374 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|